Regulus Therapeutics Inc. (RGLS) Description, Stock price, News & Info.

#ThinkSabio Latest News

Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429)